Corticosterone  别名:17-Deoxycortisol; 11β,21-Dihydroxyprogesterone; Kendall's compound B; 皮质酮

目录号 M5533

Corticosterone(皮质酮)是一种实验用具口服活性的甾体激素。Corticosterone 常用于构建动物应激相关模型。此外,Corticosterone 还可调节哺乳动物体内的能量代谢和免疫反应。Corticosterone 皮质酮可通过 SGK 诱导的 GDI 磷酸化增加 Rab 介导的 AMPAR 膜运输。

Corticosterone结构式

  CAS No.:50-22-6

规格 价格 库存状态
Free Sample (0.5-1 mg)  ¥ 0 现货
10mM*1mL in DMSO ¥ 400 现货
50mg ¥ 400 现货
100mg ¥ 660 现货
*AbMole所有产品仅供有资质的科研机构或医药企业进行科学研究或药证申报用途,不能被用于人体和任何其它用途。我们不向任何个人或非科研性质的机构提供产品和服务。
质量标准及产品资料
化学性质/溶解性/储存
分子量 346.46
分子式 C21H30O4
CAS号 50-22-6
中文名称 皮质酮;皮质甾酮
溶解性(仅列举部分溶剂) DMSO 90 mg/mL
Ethanol 10 mg/mL
储存条件 粉末型式       -20°C   3年;4°C   2年
溶于溶剂       -80°C   6个月;-20°C   1个月
运输方式 冰袋运输,根据产品的不同,可能会有相应调整。

*不同实验中用到的溶剂可能不同,具体实验所需溶剂及溶解方法请参考相关文献描述。

生物活性

Corticosterone (17-Deoxycortisol) 是一种具有口服活性的,由肾上腺皮质产生的糖皮质激素,在调节边缘系统的神经元功能方面起着重要作用。Corticosterone 皮质酮可通过 SGK 诱导的 GDI 磷酸化增加 Rab 介导的 AMPAR 膜运输。Corticosterone作用于单胺转运体, 有效抑制有机阳离子转运体。Corticosterone 还能干扰树突状细胞的成熟,具有较好的免疫抑制活性。

在体内,Corticosterone 皮质酮导致BMDC细胞诱导新生CD8+T细胞的能力明显下降。Corticosterone 皮质酮(0.03或1mg/kg;s.c.;单次)可下调大鼠齿状回和CA1的BDNF mRNA表达。


动物实验配制方法剂量(摘自公开文献,仅供参考)

1) ICR mice (male, 7 weeks old, weighing 25–28 g) were purchased from KOATECH Animal Inc. The mice had ad libitum access to food and water in a climate-controlled chamber (temperature, 21 ± 2 °C and light–dark cycle, 24 h, lights on at 07:00, and lights off at 19:00). All mice (n = 4 per cage) were habituated to the facility for 1 week prior to starting the experiments. To induce depression-like behavior, a high dose of CORT was intraperitoneally (i.p.) injected according to a previous study. CORT was dissolved in 0.9% (w/v) saline containing 0.1% dimethyl sulfoxide (DMSO) and 1% Tween-80. St. John’s wort (80% MeOH extract, dried powder of Hypericum japonicum), which was the positive control, and PRE was dissolved in distilled water. The mice were randomly assigned to six groups (n = 8): (1) sham, (2) control, (3) St. John’s wort 300 mg/kg, (4) PRE 30 mg/kg, (5) PRE 100 mg/kg, and (6) PRE 300 mg/kg. Mice in the control and sample-treated groups were administered CORT (40 mg/kg, i.p.) once daily, while those in the sham group were treated with an equal volume of vehicle.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182056/


2) Male ICR mice weighing 18–22 g were procured from the Hunan Slac Animal Center, Changsha, China. The mice were housed ten per cage except for the sucrose preference test. The environment was maintained with a 12-h light/dark cycle (08:00–20:00). Ambient temperature and relative humidity were maintained at 22 ± 2 °C and at 40%–60%. The mice had free access to drink and food. After one week of adaptation, the mice were randomly divided into six groups (n = 10): (1) Control group: saline (p.o) + saline (s.c); (2) CORT-vehicle group: saline (p.o) + CORT (s.c); (3) Res group: resveratrol (50 mg/kg, p.o) + CORT (s.c); (4) Res group: resveratrol (100 mg/kg, p.o) + CORT (s.c); (5) Flu group: fluoxetine (20 mg/kg, p.o) + CORT (s.c); (6) Piog group: pioglitazone (10 mg/kg, p.o) + CORT (s.c). The dose of CORT was 40 mg/kg. The preparation of CORT solution was in line with our previous study. In brief, the CORT was dissolved in a saline solution containing 0.1% dimethyl sulfoxide and 0.1% Tween-80.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274283/


实验参考
蛋白/细胞实验

下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。

浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.8863 mL 14.4317 mL 28.8634 mL
5 mM 0.5773 mL 2.8863 mL 5.7727 mL
10 mM 0.2886 mL 1.4432 mL 2.8863 mL

*吸湿的DMSO对产品的溶解度有显著影响,请使用新开封的DMSO;
 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。


质量   浓度   体积   分子量*
 =   x   x 

细胞系 PC12 cells
方法 PC12 cells were treated with 200 μM of corticosterone in the absence or presence of different concentrations of RES for 24 h. Then, cell viability was measured by Cell Counting Kit-8 assay. Apoptosis of PC12 cells was measured by Annexin V-FITC and Propidium iodide (PI) labelling. The expression of apoptosis-related proteins including Bax, Bcl-2, caspase-3 was determined by western blotting.
浓度 200 μM
处理时间 24 h

* 上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。

动物实验

建议您制定动物给药及实验方案时,尽量参考已发表的相关实验文献(溶剂种类及配比众多,简单地溶解目的化合物,并不能解决动物给药依从性、体内生物利用度、组织分布等相关问题,未必能保证目的化合物在动物体内充分发挥生物学效用)。
体内实验的工作液,建议您现用现配,当天使用;如在配制过程中出现沉淀、析出现象,可以通过超声和(或)加热的方式助溶。
切勿一次性将产品全部溶解。


动物实验方案计算器

请在下面的计算器中,输入您的动物实验相关数据并点击计算,即可得到该实验的总需药量和工作液终浓度。
例如您给药剂量是10 mg/kg,平均每只动物的体重为20 g,每只动物的给药体积是100 μL,动物数量为20只,则该动物实验的总需药量为4 mg,工作液终浓度为2 mg/mL。

mg/kg
uL
该动物实验的总需药量为 mg
工作液终浓度2 mg/mL

1:鉴于实验过程的损耗,建议您至少多配1-2只动物的量;
2:为该产品最终给药时的浓度。


动物模型 Male C57BL/6N mice
配制 Saline containing 0.1% dimethyl sulfoxide (DMSO) and 0.1% Tween-80
剂量 20 mg/kg
给药处理 Subcutaneously

* 上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。

参考文献

[1] Pinson SE, et al. J Comp Physiol B. Timing matters: corticosterone injections 4 h before ovulation bias sex ratios towards females in chickens.

以上参考文献由AI整理,仅供参考,AbMole 尚未独立确认这些文献的准确性。






关键词:Corticosterone, 17-Deoxycortisol; 11β,21-Dihydroxyprogesterone; Kendall's compound B, Corticosterone供应商, GCR抑制剂, 购买Corticosterone, Corticosterone溶解度, Corticosterone结构式







产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。

Copyright © 2010-2026 AbMole版权所有